Option Care Health (NASDAQ:OPCH) Stock Rating Lowered by The Goldman Sachs Group

Option Care Health (NASDAQ:OPCH - Get Free Report) was downgraded by The Goldman Sachs Group from a "buy" rating to a "neutral" rating in a research report issued to clients and investors on Monday, Marketbeat reports. They presently have a $27.00 target price on the stock. The Goldman Sachs Group's target price points to a potential upside of 20.05% from the company's previous close.

OPCH has been the subject of a number of other reports. Truist Financial cut their price target on Option Care Health from $41.00 to $34.00 and set a "buy" rating for the company in a report on Friday. Bank of America cut Option Care Health from a "buy" rating to a "neutral" rating and cut their price target for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. Barrington Research cut their price target on Option Care Health from $40.00 to $32.00 and set an "outperform" rating for the company in a report on Thursday. Jefferies Financial Group cut Option Care Health from a "buy" rating to a "hold" rating and cut their price target for the company from $38.00 to $26.00 in a report on Thursday. Finally, JMP Securities lifted their price target on Option Care Health from $36.00 to $37.00 and gave the company a "market outperform" rating in a report on Monday, September 30th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, Option Care Health has an average rating of "Moderate Buy" and a consensus price target of $30.83.

Option Care Health Price Performance

Shares of NASDAQ OPCH traded down $1.62 during midday trading on Monday, reaching $22.49. 3,605,767 shares of the company traded hands, compared to its average volume of 1,483,424. The firm has a market cap of $3.83 billion, a PE ratio of 19.16, a PEG ratio of 1.74 and a beta of 1.32. The stock's 50-day simple moving average is $30.49 and its 200-day simple moving average is $29.91. Option Care Health has a 12 month low of $22.46 and a 12 month high of $34.63. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.36 and a current ratio of 1.73.

Insiders Place Their Bets

In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the business's stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the sale, the chief financial officer now directly owns 247,317 shares of the company's stock, valued at approximately $7,654,461.15. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other news, CFO Michael H. Shapiro sold 23,217 shares of the business's stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the transaction, the chief financial officer now directly owns 247,317 shares in the company, valued at approximately $7,654,461.15. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the business's stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the transaction, the director now owns 21,339 shares of the company's stock, valued at $663,429.51. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.64% of the company's stock.

Hedge Funds Weigh In On Option Care Health

Institutional investors have recently modified their holdings of the stock. Harbor Capital Advisors Inc. grew its position in shares of Option Care Health by 317.9% in the 2nd quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company's stock valued at $2,670,000 after purchasing an additional 73,312 shares during the period. Comerica Bank grew its position in shares of Option Care Health by 6.5% in the 1st quarter. Comerica Bank now owns 760,915 shares of the company's stock valued at $25,521,000 after purchasing an additional 46,639 shares during the period. Janus Henderson Group PLC grew its position in shares of Option Care Health by 182.9% in the 1st quarter. Janus Henderson Group PLC now owns 227,135 shares of the company's stock valued at $7,617,000 after purchasing an additional 146,837 shares during the period. Edgestream Partners L.P. grew its position in shares of Option Care Health by 96.8% in the 2nd quarter. Edgestream Partners L.P. now owns 351,476 shares of the company's stock valued at $9,736,000 after purchasing an additional 172,845 shares during the period. Finally, XTX Topco Ltd acquired a new position in shares of Option Care Health in the 2nd quarter valued at approximately $973,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.